238 related articles for article (PubMed ID: 24410339)
21. HMGA1 amplifies Wnt signalling and expands the intestinal stem cell compartment and Paneth cell niche.
Xian L; Georgess D; Huso T; Cope L; Belton A; Chang YT; Kuang W; Gu Q; Zhang X; Senger S; Fasano A; Huso DL; Ewald AJ; Resar LMS
Nat Commun; 2017 Apr; 8():15008. PubMed ID: 28452345
[TBL] [Abstract][Full Text] [Related]
22. HAND1 gene expression is negatively regulated by the High Mobility Group A1 proteins and is drastically reduced in human thyroid carcinomas.
Martinez Hoyos J; Ferraro A; Sacchetti S; Keller S; De Martino I; Borbone E; Pallante P; Fedele M; Montanaro D; Esposito F; Cserjesi P; Chiariotti L; Troncone G; Fusco A
Oncogene; 2009 Feb; 28(6):876-85. PubMed ID: 19060921
[TBL] [Abstract][Full Text] [Related]
23. Clinical Implications of Extracellular HMGA1 in Breast Cancer.
Méndez O; Pérez J; Soberino J; Racca F; Cortés J; Villanueva J
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31779212
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of high mobility group A1 protein in human uveal melanomas: implication for prognosis.
Qu Y; Wang Y; Ma J; Zhang Y; Meng N; Li H; Wang Y; Wei W
PLoS One; 2013; 8(7):e68724. PubMed ID: 23935884
[TBL] [Abstract][Full Text] [Related]
25. HMGA1 promotes breast cancer angiogenesis supporting the stability, nuclear localization and transcriptional activity of FOXM1.
Zanin R; Pegoraro S; Ros G; Ciani Y; Piazza S; Bossi F; Bulla R; Zennaro C; Tonon F; Lazarevic D; Stupka E; Sgarra R; Manfioletti G
J Exp Clin Cancer Res; 2019 Jul; 38(1):313. PubMed ID: 31311575
[TBL] [Abstract][Full Text] [Related]
26. HMGA1 is a novel transcriptional regulator of the FoxO1 gene.
Arcidiacono B; Chiefari E; Messineo S; Bilotta FL; Pastore I; Corigliano DM; Foti DP; Brunetti A
Endocrine; 2018 Apr; 60(1):56-64. PubMed ID: 29052178
[TBL] [Abstract][Full Text] [Related]
27. HMGA1 interacts with β-catenin to positively regulate Wnt/β-catenin signaling in colorectal cancer cells.
Xing J; Cao G; Fu C
Pathol Oncol Res; 2014 Oct; 20(4):847-51. PubMed ID: 24696416
[TBL] [Abstract][Full Text] [Related]
28. HMGA1 negatively regulates NUMB expression at transcriptional and post transcriptional level in glioblastoma stem cells.
Puca F; Tosti N; Federico A; Kuzay Y; Pepe A; Morlando S; Savarese T; D'Alessio F; Colamaio M; Sarnataro D; Ziberi S; De Martino M; Fusco A; Battista S
Cell Cycle; 2019 Jul; 18(13):1446-1457. PubMed ID: 31116627
[TBL] [Abstract][Full Text] [Related]
29. MiR-195 reverses 5-FU resistance through targeting HMGA1 in gastric cancer cells.
Wang CQ
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3771-3778. PubMed ID: 31115003
[TBL] [Abstract][Full Text] [Related]
30. HMGA1 promoting gastric cancer oncogenic and glycolytic phenotypes by regulating c-myc expression.
Cao XP; Cao Y; Zhao H; Yin J; Hou P
Biochem Biophys Res Commun; 2019 Aug; 516(2):457-465. PubMed ID: 31229266
[TBL] [Abstract][Full Text] [Related]
31. HMGA1 down-regulation is crucial for chromatin composition and a gene expression profile permitting myogenic differentiation.
Brocher J; Vogel B; Hock R
BMC Cell Biol; 2010 Aug; 11():64. PubMed ID: 20701767
[TBL] [Abstract][Full Text] [Related]
32. HMGA1 Overexpression is Associated With the Malignant Status and Progression of Breast Cancer.
Qi C; Cao J; Li M; Liang C; He Y; Li Y; Li J; Zheng X; Wang L; Wei B
Anat Rec (Hoboken); 2018 Jun; 301(6):1061-1067. PubMed ID: 29316384
[TBL] [Abstract][Full Text] [Related]
33. HMGA1 in cancer: Cancer classification by location.
Wang Y; Hu L; Zheng Y; Guo L
J Cell Mol Med; 2019 Apr; 23(4):2293-2302. PubMed ID: 30614613
[TBL] [Abstract][Full Text] [Related]
34. A novel HMGA1-CCNE2-YAP axis regulates breast cancer aggressiveness.
Pegoraro S; Ros G; Ciani Y; Sgarra R; Piazza S; Manfioletti G
Oncotarget; 2015 Aug; 6(22):19087-101. PubMed ID: 26265440
[TBL] [Abstract][Full Text] [Related]
35. Mass spectrometric analysis of high-mobility group proteins and their post-translational modifications in normal and cancerous human breast tissues.
Zou Y; Wang Y
J Proteome Res; 2007 Jun; 6(6):2304-14. PubMed ID: 17455969
[TBL] [Abstract][Full Text] [Related]
36. Eliminating Cancer Stem Cells by Targeting Embryonic Signaling Pathways.
Oren O; Smith BD
Stem Cell Rev Rep; 2017 Feb; 13(1):17-23. PubMed ID: 27730468
[TBL] [Abstract][Full Text] [Related]
37. The Wnt/β-catenin/T-cell factor 4 pathway up-regulates high-mobility group A1 expression in colon cancer.
Bush BM; Brock AT; Deng JA; Nelson RA; Sumter TF
Cell Biochem Funct; 2013 Apr; 31(3):228-36. PubMed ID: 22961697
[TBL] [Abstract][Full Text] [Related]
38. Differential expression and prognostic value of HMGA1 in pancreatic head and periampullary cancer.
van der Zee JA; ten Hagen TL; Hop WC; van Dekken H; Dicheva BM; Seynhaeve AL; Koning GA; Eggermont AM; van Eijck CH
Eur J Cancer; 2010 Dec; 46(18):3393-9. PubMed ID: 20724141
[TBL] [Abstract][Full Text] [Related]
39. Natural Compounds Targeting Cancer Stem Cells: A Promising Resource for Chemotherapy.
Das PK; Zahan T; Abdur Rakib M; Khanam JA; Pillai S; Islam F
Anticancer Agents Med Chem; 2019; 19(15):1796-1808. PubMed ID: 31272363
[TBL] [Abstract][Full Text] [Related]
40. The association between S100A13 and HMGA1 in the modulation of thyroid cancer proliferation and invasion.
Zhong J; Liu C; Chen YJ; Zhang QH; Yang J; Kang X; Chen SR; Wen GB; Zu XY; Cao RX
J Transl Med; 2016 Mar; 14():80. PubMed ID: 27008379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]